Enrollment is open for a phase 2 trial of a drug normally used to treat abnormal heart rhythms that showed promise in ALS mouse studies

Posted on Monday, July 15, 2013 - 05:00, By: Amy Madsen
Update (June 16, 2014): This trial is now closed to new participants. Update (Jan. 28, 2014): This story has been updated with new contact information for the Boston and St. Louis centers. original story:

Clinical trials expert Merit Cudkowicz discusses why it’s so hard to find therapies for ALS

Posted on Monday, April 1, 2013 - 09:19, By: Amy Madsen
Put together the words amyotrophic lateral sclerosis (ALS) and the phrase clinical trials expert, and one name that is sure to follow is Merit Cudkowicz. Cudkowicz is chief of neurology and director of the Neurology Clinical Trials Unit and the ALS Center at Massachusetts General Hospital (MGH) in...